Get started
Author

Matthew A. Ciorba

Observed name: Matthew Ciorba
ORCID: 0000-0002-7656-0982
Observed ORCID: 0000-0002-7656-0982
OpenAlex ID: A5122760123
BPS2026 – LRRC26-associated BK channels regulate membrane potential and intracellular calcium signaling in colonic goblet cells
2026 · Gardenia Payne Deliz, Pedro L. Martinez-Espinosa, et al. · Biophysical Journal
Figure 2 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Table S1 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Table S3 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Figure S1 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Real World Durability of Response and Remission With Upadacitinib in Ulcerative Colitis: a Multicenter Study
2026 · Katherine Huang, Arun Chandnani, et al. · Inflammatory Bowel Diseases
PDF
Figure 3 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Figure S5 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Figure 4 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Loss of Cgnl1 Contributes to Very Early Onset Ibd
2026 · Kaiming Ma, Yangzhuangzhuang Zhu, et al. · Inflammatory Bowel Diseases
Supplemental Table S4 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Methods from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Loss of Cgnl1 Contributes to Very Early Onset Ibd
2026 · Kaiming Ma, Yangzhuangzhuang Zhu, et al. · Gastroenterology
Supplemental Figure S2 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Figure 5 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Figure 1 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Figure S3 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Real World Durability of Response and Remission With Upadacitinib in Ulcerative Colitis: a Multicenter Study
2026 · Katherine Huang, Arun Chandnani, et al. · Gastroenterology
Supplemental Table S2 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Supplemental Figure S4 from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Data from Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines
2026 · Alexander Zheleznyak, Dhanusha Duraiyan, et al.
Neoadjuvant epacadostat (INCB024360) combined with short course radiotherapy in patients with locally advanced rectal cancer: Efficacy and safety from a phase 2 trial.
2026 · Moh'd M. Khushman, Haeseong Park, et al. · Journal of Clinical Oncology
PDF
Works count: 22
Citation count:
H-index:
I10-index:
Year
Topic
Type